When NPWT Dressing Kits Are Not Interchangeable Across PumpsWhy FDA 510(k) indications for use, CMS integrated-system billing rules and product code OMP dictate companion-pump matching rather than catalog-universal claims.
INSIGHTS
Research and practical buying guidance.
Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.
LATEST ARTICLES
Practical guidance from the VEMERIX team.
When a Sample Lot Is Not the Commercial Lot: Why an ISO 11135:2014 Cycle File and FDA Rec 14-529 Do Not Adopt a New Size, Blister or Load, Why AAMI TIR28 Rec 14-603 Is the Product-Adoption Overlay, Why Annex E Single-Batch Release Is Not Adoption, and Why ISO/FDIS 11135 Is Not the Cycle FileAn incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital buyers, and OEM engineers navigating ethylene-oxide cycle certificates, product adoption, single-batch release, and commercial pallet density across the US FDA, ISO, and AAMI frameworks in September 2026.
When a Tender Demands 75 Percent or 80 Percent Remaining Shelf Life on a Sterile Device: Why FDA April 1991 and EU MDR GSPR 11.4 Do Not Set a Remaining-Percentage Statute, Why UNICEF October 2023 Uses Two Thirds and a Five-Year Floor, Why WHO TRS 1044 Annex 8 Is a Months Table After Risk Assessment, and Why ISO 11607 Is Not the Dock ClockAn operational procurement and regulatory guide for international medical-device distributors, hospital buyers, and OEM sellers navigating remaining-shelf-life tender clauses, incoming-inspection dock tests, and labelled expiration dates across the US, EU, UNICEF, and WHO frameworks in September 2026.
Which ISO 11607 Packaging Declaration of Conformity Survives 20 December 2026: Why FDA Rec 14-594 and 14-595 Name 2019 Including AMD1:2023, Why Rec 14-530 and 14-531 Remain Acceptable Until That Date, Why Decision (EU) 2024/815 Already Cites EN ISO 11607-1:2020/A1:2023, and Why GB/T 19633.1-2024 Is the 2019 IDT Implemented 1 December 2025An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating sterile-barrier packaging validation files, declarations of conformity, and recognition timelines across the US, EU, and China in September 2026.
Which ISO 10993-7 Edition Governs an EO Residual CoA in 2026: Why ISO 10993-7:2026 Is Not FDA Recognition 2-275, Why the 25 May 2026 Part 1 Update Did Not Move Part 7, and Why MDCG 2024-13 Still Names EN ISO 10993-7:2008+A1:2022An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating EO-sterilized single-use device residual certificates of analysis, dissipation curves, and regulatory recognition across the US, EU, and China in 2026.
How to Qualify a Chinese Medical-Device Factory After NMPA Announcement 107: Why ISO 13485, MDSAP and a 2014 GMP Certificate Are Not the 1 November 2026 File, What Articles 2–3, 17–21, 32, 91, 104 and 107–113 Require, and Why a Production License or NMPA Registration Is Not China GMPAn operational factory-qualification and supplier-audit guide for international distributors, private-label/OEM buyers and hospital procurement teams evaluating Chinese sterile medical-device manufacturers under NMPA Announcement No. 107 of 2025, the 132-article Good Manufacturing Practice effective 1 November 2026, and the simultaneous repeal of CFDA Announcement No. 64 of 2014.
How to Place a Medical Device on the Mexican Market in 2026: Registro Sanitario versus 2010 FDA/Canada and 2012 Japan Equivalence Agreements versus Option F Abbreviated Pathway under the 18 July 2025 Lineamientos, IMDRF Management Committee versus MDSAP for GMP Certificates Only, Homoclave COFEPRIS-04-050 Still Physical, the 20 August 2026 Visor, Official LFD Article 195-A Fees, and Why CE / 510(k) / NMPA / MDSAP Do Not Replace a Mexican Sanitary RegistrationAn operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Mexican market under Ley General de Salud Articles 262 and 376, RIS Article 83 risk classes, the 2010 FDA/Canada and 2012 Japan equivalence agreements, and the 18 July 2025 Option F abbreviated pathway.
When EC REP Is Still Acceptable on a Medical Device Label After 17 June 2026: ISO 15223-1:2021/Amd 1:2025 XX REP and EU REP, Commission Implementing Decisions (EU) 2026/1231 and 2026/1313, MDCG 2021-5 Rev. 1 Appendix, FDA Recognition 5-148 versus 5-134, 21 CFR 801.15, and Why a Notified Body Does Not Have to Pre-Approve the Editorial ChangeAn operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality teams evaluating CE-marked sterile single-use devices under ISO 15223-1 clause 5.1.2, EU MDR/IVDR harmonised-standard withdrawal dates, and US FDA consensus-recognition clocks.
Public Price Benchmarks for Single-Use Consumables (2026): Medicare, UNICEF and the US Import Work OrderKeep reimbursement, procurement awards and landed costs separate when building a consumables bid.
How to Place a Medical Device on the Japanese Market in 2026: Marketing Authorization Holder versus Designated MAH under PMD Act Articles 23-2 and 23-2-17, Foreign Manufacturer Registration under Article 23-2-4 versus Drug Accreditation, Todokede versus Ninsho versus Shonin, Ordinance 169 and MDSAP, Official Yen Fees, and Why CE / 510(k) / NMPA / HSA Do Not Replace a Japanese LicenceAn operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Japanese market under PMD Act Articles 23-2, 23-2-4, and 23-2-17, MHLW Ordinance 169, and official PMDA user-fee schedules.
How to Review a Supplier's Production and Process-Control File After QMSR: Why 21 CFR 820.70, 820.75 and 820.80 Are Reserved, What ISO 13485 Clause 7.5 and 21 CFR 820.45 Require, What Compliance Program 7382.850 Inspects under Production and Service Provision, and Why a DHR Binder or Contract-Sterilizer Listing Is Not the FileA field-by-field file-review guide for medical device distributors, OEM buyers, and hospital procurement teams evaluating sterile single-use suppliers after 2 February 2026: why 21 CFR 820.70, 820.75, and 820.80 are reserved, what ISO 13485 Clause 7.5 and 21 CFR 820.45 mandate for production, process validation, and labeling inspection, and how FDA Compliance Program 7382.850 audits Production and Service Provision.
How to Place a Medical Device on the Korean Market in 2026: Import Business Permission versus Item Notification, Certification or Approval, KGMP and QMS Conformity Recognition after Act No. 21263, Official Fees under Enforcement Rule Article 65, and Why CE / 510(k) / NMPA / HSA Do Not Replace an MFDS LicenceAn operational regulatory guide for international medical device distributors, OEM buyers and manufacturers placing sterile single-use devices on the Republic of Korea market under the Medical Devices Act, Enforcement Rule Article 65 fees, and Act No. 21263 QMS conformity rules.
How to Review a Supplier's CAPA and Complaint File After QMSR: Why 21 CFR 820.100 and 820.198 Are Reserved, What ISO 13485 Clauses 8.2.2 / 8.3 / 8.5.2 / 8.5.3 and 21 CFR 820.35 Require, What Compliance Program 7382.850 Inspects, and Why an MDR Report Is Not the Complaint FileAn incoming audit guide for medical device distributors, OEMs, and hospital procurement teams: why 21 CFR 820.100 and 820.198 are reserved under QMSR, how ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, and 8.5.3 carry the legal duties, what 21 CFR 820.35 adds on top, what CP 7382.850 inspects under Measurement, Analysis, and Improvement, why an MDR report is not the complaint file, and a 7-point buyer acceptance protocol.
How to Place a Medical Device on the Singapore Market in 2026: SMDR versus Class A Notification versus Dealer Licence versus Registrant, GN-15 R13 Evaluation Routes and Malaysia MDA Reliance, Official Fees as of 26 March 2026, and Why CE / 510(k) / NMPA Do Not Replace an HSA ListingA definitive, decision-led guide for international manufacturers and Singapore distributors: navigating Singapore Health Sciences Authority (HSA) medical device registration, SMDR listings, Class A SHARE notifications, Registrant mandates, dealer licences, GN-15 R13 evaluation pathways, and 2026 fee cards.
Disposable Circumcision Device Manufacturers (2026): An Evidence-Verified Global Supplier Landscape for DistributorsA register-first supplier map that separates brands, legal manufacturers, sterilizers, listing establishments, certificate holders and distributors before an RFQ is issued.
How to Review a Supplier's Purchasing Controls and Outsourcing File After QMSR: Why 21 CFR 820.50 Is Reserved, What ISO 13485 Clauses 4.1.5 and 7.4 Require, What Compliance Program 7382.850 Inspects, and a Buyer Acceptance ChecklistA practical buyer's audit guide for medical device purchasing and outsourcing files: why 21 CFR 820.50 is reserved under QMSR, how ISO 13485 Clauses 4.1.5 and 7.4 carry the legal duties, what FDA Compliance Program 7382.850 inspects, why supplier-audit reports are no longer exempt, and a 7-point incoming acceptance checklist.
How to Place a Medical Device on the Canadian Market in 2026: Medical Device Licence versus Medical Device Establishment Licence versus Class I, MDSAP as a Licence Condition not a Substitute, Official Fees as of 1 April 2026, and Why SOR/2026-110's Coming-into-Force Date Is Counted from Registration not from the MDCP BulletinAn operational decision guide for international medical-device distributors, private-label/OEM buyers, and overseas manufacturers: navigating Health Canada Medical Device Licences (MDL) under SOR/98-282 s 26, Medical Device Establishment Licences (MDEL) under GUI-0016 Table 1, the mandatory MDSAP quality filing condition, Schedule 1 risk classification, official 1 April 2026 fees including the private-label MDL, MDALL versus MDEL listing verification boundaries, and the SOR/2026-110 modernization coming-into-force timeline.
How to Place a Medical Device on the Australian Market in 2026: ARTG Inclusion versus Australian Sponsor versus Manufacturer Evidence, TGA Classification, Comparable Overseas Regulator Evidence, and Why 1 July 2026 UDI Starts Only After You Know the TGA ClassAn operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating Australian Register of Therapeutic Goods (ARTG) inclusion under the Therapeutic Goods Act 1989, the Australian sponsor mandate, Manufacturer Evidence pre-approval, TGA risk classification (Classes I, IIa, IIb, III), Comparable Overseas Regulator (COR) pathways, July 2026 fee schedules, and the class-phased 1 July 2026 Unique Device Identification (AusUDID) rollout.
How to Review a Supplier's ISO 14971 Risk Management File: What QMSR Actually Requires After 2 February 2026, EN ISO 14971:2019+A11:2021 for MDR, China's GB/T 42062-2022, and a Buyer Acceptance ChecklistA practical buyer's audit guide for medical device risk management files: separating ISO 13485 QMSR process mandates from ISO 14971 conformity, verifying EN ISO 14971:2019+A11:2021 for EU MDR, navigating China's GB/T 42062-2022, and executing a 7-point incoming acceptance protocol.
How to Place a Medical Device on the Saudi Market in 2026: MDMA versus Authorized Representative versus Establishment License, SFDA Classes A–D, 2025 Fees, and the May 2026 Bundling RulesAn operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating the Kingdom of Saudi Arabia's MDMA requirements under Law M/54, the Technical File Assessment route, SFDA Classes A–D (MDS-G008), the May 2025 fee schedule, the 3 May 2026 bundling criteria (MDS-G028), Authorized Representative mandates, importer establishment licensing, and port-clearance verification.
Which Part Is the Device? How Public Registers Separate Endovenous Laser Fibers, Generators and Kits (2026)Buyers say ‘the laser.’ Certificates name a fiber, a generator, or a vague system.
Sterile Hypodermic Needle Specification and Incoming Acceptance: ISO 7864 Dimensions, ISO 9626 Tubing, ISO 6009 Colour Coding, Luer Fit, and the FDA FMI / China Class III Evidence PackA specification and lot-acceptance guide for sterile single-use hypodermic needles: mapping ISO 7864, ISO 9626 tubing, ISO 6009 colour coding, ISO 80369-7 Luer fit, FDA product code FMI 510(k) evidence, China Class III registration requirements, and the GB 15811-2025 transition timeline.
How to Place a Medical Device on the Great Britain Market in 2026: When a Valid CE Mark Is Enough, When UKCA Is Required, Appointing a UK Responsible Person, MHRA Registration, and the June 2025 PMS Rules That Already ApplyAn operational decision guide for international distributors, OEM buyers, and non-UK manufacturers: navigating Great Britain's CE-recognition timelines (2028 vs 2030), UKCA requirements under UK MDR 2002, UK Responsible Person mandates, DORS registration and 2026 fees, Northern Ireland EUDAMED rules, and the in-force June 2025 post-market surveillance obligations.
How to Review a Supplier's ISO 10993 Biocompatibility File: Endpoints by Contact and Duration, the 2025 Edition Transition (FDA Deadline July 2029), and a US/EU/China Acceptance ChecklistA practical buyer's audit guide for medical device biological safety files: matching endpoints to contact category and duration, verifying test-article final form, navigating the ISO 10993-1:2025 transition across FDA, EU MDR and China NMPA, and spotting disqualifying file gaps.
How to Verify a Certificate of Free Sale for a Medical Device: A Distributor's Guide to CFS and Export Certificates, Checking Issuing Authorities (FDA, EU, UK MHRA, NMPA) and Spotting Red FlagsA practical field-by-field verification guide for medical device export certificates: authenticating FDA CFGs via FECV, validating EU MDR Article 60 certificates, checking UK MHRA free-sale documents, navigating China's May 2026 export certificate reforms, and matching scope to your RFQ.
How to Verify an ISO 13485 Certificate: A Distributor's Guide to Reading QMS Certificate Scope, Checking Certification-Body Accreditation, and Telling a Real Certificate From a Fake OneA practical field-by-field certificate reading guide, scope-to-SKU matching table, IAF CertSearch and accreditation-body verification workflow, 2026 Global ACI transition decoder, fake/mill certificate triage, and distribution agreement evidence schedule.
How to Verify an FDA 510(k) Clearance: A Distributor's Guide to Checking a K Number, Reading the Clearance Record, and Telling Clearance, Registration and Listing ApartA practical five-check verification workflow, five-field matching grid, registration-versus-clearance decoder, exempt-device exception rules, and agreement evidence schedule for international medical-device distributors.
How to Verify a CE Certificate for a Medical Device: A Distributor's Guide to Reading Notified-Body Certificates, NANDO Designation, Scope and Extended MDD ValidityA practical five-check verification workflow, Annex XII reading grid, NANDO designation guide, EUDAMED status decoder, and distribution-agreement schedule for international distributors qualifying European medical-device suppliers.
Registering and Distributing Disposable Circumcision Devices: A US (FDA 510(k)), EU (MDR) and China (NMPA) Market-Entry Evidence Pack for Distributors and Private-Label BuyersA multi-jurisdiction regulatory matrix and distributor evidence checklist comparing US 21 CFR 884.4530, EU MDR Class IIa Rule 6, China provincial Class II NMPA registrations, and WHO prequalification gates.
Wound Debridement Before the Vacuum: What Medicare Data Shows About Where NPWT Actually Sits in Care (2026)Medicare professional-service data and current wound guidance show why debridement and dressings define the pathway—and why NPWT remains a selective downstream adjunct.